GB

Genevieve Black

Manager, Marketing Operations at G1 Therapeutics

Genevieve Black has a diverse work experience in various roles related to compliance, marketing operations, and policy development.

Genevieve most recently worked as a Manager of Marketing Operations at G1 Therapeutics, Inc. since March 2021.

Prior to that, they held a Senior Manager position at United Therapeutics Corporation from March 2017 to March 2020, where they were responsible for coordinating and enhancing compliance operations. Genevieve'sresponsibilities included needs assessment, fair market value assessment, corporate funding, and compliance controls implementation. Genevieve also handled transparency reporting for research and general spend.

Before their role at United Therapeutics Corporation, they worked at United Therapeutics as an Associate Manager of Compliance, Policy & Education from March 2012 to March 2017. In this role, they developed quarterly compliance training for sales and marketing teams, managed the promotional review process, and chaired weekly meetings.

Genevieve'searlier experience includes working as a Marketing Materials Specialist at Grifols from July 2006 to February 2012. Genevieve oversaw the legal, medical, and regulatory review process for product promotion, as well as managed warehousing and printing tasks.

Genevieve Black holds a Bachelor of Arts (BA) degree from St. Francis Xavier University. The specific field of study for their Bachelor's degree is not provided. In addition to their undergraduate education, they have obtained certifications in Project Management Tips from LinkedIn in November 2022 and Certified Compliance & Ethics Professional from the Society of Corporate Compliance and Ethics (SCCE) in August 2012.

Location

Butner, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


G1 Therapeutics

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).


Industries

Headquarters

NC, United States

Employees

51-200

Links